POSTER: MM-906 First-in-Human Study of JNJ-79635322 (JNJ-5322), a Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 13-1-2026, 22:32